1. Home
  2. ENVB vs STSS Comparison

ENVB vs STSS Comparison

Compare ENVB & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • STSS
  • Stock Information
  • Founded
  • ENVB 1994
  • STSS 2017
  • Country
  • ENVB United States
  • STSS United States
  • Employees
  • ENVB N/A
  • STSS N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • STSS Medical/Dental Instruments
  • Sector
  • ENVB Health Care
  • STSS Health Care
  • Exchange
  • ENVB Nasdaq
  • STSS Nasdaq
  • Market Cap
  • ENVB 3.2M
  • STSS 3.3M
  • IPO Year
  • ENVB N/A
  • STSS 2022
  • Fundamental
  • Price
  • ENVB $1.28
  • STSS $4.73
  • Analyst Decision
  • ENVB Strong Buy
  • STSS
  • Analyst Count
  • ENVB 1
  • STSS 0
  • Target Price
  • ENVB $10.00
  • STSS N/A
  • AVG Volume (30 Days)
  • ENVB 42.6K
  • STSS 1.5M
  • Earning Date
  • ENVB 05-19-2025
  • STSS 05-16-2025
  • Dividend Yield
  • ENVB N/A
  • STSS N/A
  • EPS Growth
  • ENVB N/A
  • STSS N/A
  • EPS
  • ENVB N/A
  • STSS N/A
  • Revenue
  • ENVB N/A
  • STSS N/A
  • Revenue This Year
  • ENVB N/A
  • STSS N/A
  • Revenue Next Year
  • ENVB N/A
  • STSS N/A
  • P/E Ratio
  • ENVB N/A
  • STSS N/A
  • Revenue Growth
  • ENVB N/A
  • STSS N/A
  • 52 Week Low
  • ENVB $1.01
  • STSS $3.30
  • 52 Week High
  • ENVB $222.75
  • STSS $5,445.00
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 31.74
  • STSS 29.89
  • Support Level
  • ENVB $1.23
  • STSS $4.45
  • Resistance Level
  • ENVB $1.40
  • STSS $5.18
  • Average True Range (ATR)
  • ENVB 0.09
  • STSS 1.05
  • MACD
  • ENVB 0.15
  • STSS 3.30
  • Stochastic Oscillator
  • ENVB 48.15
  • STSS 7.50

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: